Literature DB >> 32215686

Stress-induced impairment in fear discrimination is causally related to increased kynurenic acid formation in the prefrontal cortex.

Alex D Klausing1, Tsutomu Fukuwatari1,2, David J Bucci3, Robert Schwarcz4.   

Abstract

RATIONALE: Stress is related to cognitive impairments which are observed in most major brain diseases. Prior studies showed that the brain concentration of the tryptophan metabolite kynurenic acid (KYNA) is modulated by stress, and that changes in cerebral KYNA levels impact cognition. However, the link between these phenomena has not been tested directly so far.
OBJECTIVES: To investigate a possible causal relationship between acute stress, KYNA, and fear discrimination.
METHODS: Adult rats were exposed to one of three acute stressors-predator odor, restraint, or inescapable foot shocks (ISS)-and KYNA in the prefrontal cortex was measured using microdialysis. Corticosterone was analyzed in a subset of rats. Another cohort underwent a fear discrimination procedure immediately after experiencing stress. Different auditory conditioned stimuli (CSs) were either paired with foot shock (CS+) or were non-reinforced (CS-). One week later, fear was assessed by re-exposing rats to each CS. Finally, to test whether stress-induced changes in KYNA causally impacted fear discrimination, a group of rats that received ISS were pre-treated with the selective KYNA synthesis inhibitor PF-04859989.
RESULTS: ISS caused the greatest increase in circulating corticosterone levels and raised extracellular KYNA levels by ~ 85%. The two other stressors affected KYNA much less (< 25% increase). Moreover, only rats that received ISS were unable to discriminate between CS+ and CS-. PF-04859989 abolished the stress-induced KYNA increase and also prevented the impairment in fear discrimination in animals that experienced ISS.
CONCLUSIONS: These findings demonstrate a causal connection between stress-induced KYNA increases and cognitive deficits. Pharmacological manipulation of KYNA synthesis therefore offers a novel approach to modulate cognitive processes in stress-related disorders.

Entities:  

Keywords:  Acute stress; Inescapable shock; Kynurenine aminotransferase; Tryptophan

Mesh:

Substances:

Year:  2020        PMID: 32215686      PMCID: PMC7308198          DOI: 10.1007/s00213-020-05507-x

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  80 in total

1.  Serotonergic and kynurenic pathways in rats exposed to foot shock.

Authors:  D Pawlak; Y Takada; T Urano; A Takada
Journal:  Brain Res Bull       Date:  2000-06       Impact factor: 4.077

2.  Upregulation of neuronal kynurenine 3-monooxygenase mediates depression-like behavior in a mouse model of neuropathic pain.

Authors:  Geoffroy Laumet; Wenjun Zhou; Robert Dantzer; Jules D Edralin; XiaoJiao Huo; David P Budac; Jason C O'Connor; Anna W Lee; Cobi J Heijnen; Annemieke Kavelaars
Journal:  Brain Behav Immun       Date:  2017-07-11       Impact factor: 7.217

Review 3.  The role of the kynurenine metabolism in major depression.

Authors:  Aye-Mu Myint; Markus J Schwarz; Norbert Müller
Journal:  J Neural Transm (Vienna)       Date:  2011-12-03       Impact factor: 3.575

4.  Peripheral and cerebral metabolic abnormalities of the tryptophan-kynurenine pathway in a murine model of major depression.

Authors:  Anthony Laugeray; Jean-Marie Launay; Jacques Callebert; Alexandre Surget; Catherine Belzung; Pascal R Barone
Journal:  Behav Brain Res       Date:  2010-02-12       Impact factor: 3.332

5.  Kynurenine pathway in depression: A systematic review and meta-analysis.

Authors:  Kamiyu Ogyu; Kaoruhiko Kubo; Yoshihiro Noda; Yusuke Iwata; Sakiko Tsugawa; Yuki Omura; Masataka Wada; Ryosuke Tarumi; Eric Plitman; Sho Moriguchi; Takahiro Miyazaki; Hiroyuki Uchida; Ariel Graff-Guerrero; Masaru Mimura; Shinichiro Nakajima
Journal:  Neurosci Biobehav Rev       Date:  2018-03-30       Impact factor: 8.989

6.  Tryptophan pathway alterations in the postpartum period and in acute postpartum psychosis and depression.

Authors:  Cato Veen; Aye Mu Myint; Karin M Burgerhout; Markus J Schwarz; Gregor Schütze; Steven A Kushner; Witte J Hoogendijk; Hemmo A Drexhage; Veerle Bergink
Journal:  J Affect Disord       Date:  2015-10-22       Impact factor: 4.839

7.  Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

Authors:  R W Heinrichs; K K Zakzanis
Journal:  Neuropsychology       Date:  1998-07       Impact factor: 3.295

Review 8.  The kynurenine pathway: a finger in every pie.

Authors:  Jonathan Savitz
Journal:  Mol Psychiatry       Date:  2019-04-12       Impact factor: 15.992

Review 9.  The Plasma [Kynurenine]/[Tryptophan] Ratio and Indoleamine 2,3-Dioxygenase: Time for Appraisal.

Authors:  Abdulla A-B Badawy; Gilles Guillemin
Journal:  Int J Tryptophan Res       Date:  2019-08-21

10.  CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression.

Authors:  C L Raison; R Dantzer; K W Kelley; M A Lawson; B J Woolwine; G Vogt; J R Spivey; K Saito; A H Miller
Journal:  Mol Psychiatry       Date:  2009-11-17       Impact factor: 15.992

View more
  2 in total

Review 1.  Possibility of Amino Acid Treatment to Prevent the Psychiatric Disorders via Modulation of the Production of Tryptophan Metabolite Kynurenic Acid.

Authors:  Tsutomu Fukuwatari
Journal:  Nutrients       Date:  2020-05-13       Impact factor: 5.717

2.  Heterocyclic Cathinones as Inhibitors of Kynurenine Aminotransferase II-Design, Synthesis, and Evaluation.

Authors:  Michal Maryška; Lucie Svobodová; Wim Dehaen; Martina Hrabinová; Michaela Rumlová; Ondřej Soukup; Martin Kuchař
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.